Marao, Taiba H.
HRN: 132647 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2022
MUPIROCIN 2%, 15G (TUBE)
04/09/2022
04/16/2022
TOPICAL
2%
TID
Infected Bed Sores, DM Type II
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose Decrease To BID
Final appropriateness: No Wrong Dose
Overall appropriateness: No